Establishes maximum THC potency of cannabis items and imposes excise tax of moderate and high potency cannabis items.
S4148 would amend New Jersey’s cannabis regulatory law to impose a statewide maximum THC potency of 60 percent for adult-use cannabis items and to require labeling that clearly states THC potency. It also creates a new excise tax on wholesale sales by Class 2 cannabis manufacturers for certain potency tiers: $1 per serving for cannabis items with 15 to 40 percent THC and $5 per serving for items above 40 percent THC. The bill directs the Cannabis Regulatory Commission, together with the Division of Taxation, to adopt implementing rules and administer collection and reporting of the tax.
Beyond the potency cap and tax, the bill reinforces and expands existing regulatory requirements for cannabis packaging, labeling, advertising, testing, security, recordkeeping, and youth-access restrictions. It includes detailed product disclosure requirements such as serving size, ingredient lists, allergens, source information, and warning labels, and it requires the CRC to maintain standards for testing facilities, inspections, and compliance enforcement. The bill also continues to channel cannabis-related revenues into the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund, including an underage deterrence account and social equity-related appropriations.
The bill would amend N.J.S.A. 24:6I-35 and N.J.S.A. 24:6I-50 and add a new excise-tax section in Title 54, thereby changing both cannabis regulatory and tax law. It would require the CRC to revise its regulations to incorporate a 60 percent THC cap, mandatory THC potency labeling, and a new potency-based tax structure for wholesale cannabis items. The measure would also affect cannabis manufacturers, retailers, testing facilities, and distributors by imposing additional compliance, labeling, and reporting obligations, while excluding medical cannabis transfers to alternative treatment centers from the new excise tax. Revenue from the tax would be deposited into the existing cannabis fund and used for regulatory, enforcement, social equity, and youth-prevention purposes.
No committee transcripts or recorded votes were provided, so there is no direct evidence of support or opposition from legislative debate. Based on the bill text, the policy approach is strongly regulatory and public-health oriented, emphasizing potency limits, consumer warnings, youth deterrence, and enforcement. The bill also reflects a revenue-raising and social-equity framework by directing tax proceeds into cannabis oversight, impact-zone investments, and prevention programs.
The most likely points of contention are the new THC potency cap and the excise tax on moderate- and high-potency products. Cannabis businesses may object to the added tax burden, the compliance costs associated with potency testing and labeling, and the possible market impact of limiting products above 60 percent THC. Public-health advocates and regulators are likely to support the bill’s youth-protection, packaging, and warning-label provisions, while industry stakeholders may be more concerned about whether the tax and potency restrictions could reduce consumer choice or shift sales toward lower-tax or illicit markets. The bill’s detailed advertising and packaging restrictions, and its broad CRC enforcement authority, may also draw scrutiny from business groups.